Shaun D. McMeans
2021
In 2021, Shaun D. McMeans earned a total compensation of $510.6K as Senior Vice President and Chief Financial Officer at HTG Molecular Diagnostics, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,860 |
|---|---|
| Salary | $370,000 |
| Other | $741 |
| Total | $510,601 |
McMeans received $370K in salary, accounting for 72% of the total pay in 2021.
McMeans also received $139.9K in non-equity incentive plan and $741 in other compensation.
Rankings
In 2021, Shaun D. McMeans' compensation ranked 10,680th out of 12,405 executives tracked by ExecPay. In other words, McMeans earned more than 13.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,680 out of 12,405 | 14th |
Division Manufacturing | 4,712 out of 5,494 | 14th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 639 out of 798 | 20th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 168 out of 206 | 18th |
Industry Laboratory Analytical Instruments | 80 out of 90 | 11th |
Source: SEC filing on July 7, 2022.
McMeans' colleagues
We found two more compensation records of executives who worked with Shaun D. McMeans at HTG Molecular Diagnostics in 2021.